Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Gujarat Themis BiosynNSE:GUJTHEM -1.53%64 Days Inventory is 287.17 as of Mar. 2026, which is 273% above its 10-year median of 76.91. GuruFocus rates NSE:GUJTHEM with a GF Score™ of 64/100 and a GF Value™ of ₹312.84 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 921 Drug Manufacturers companies, Gujarat Themis Biosyn ranks better than 69.06% on this metric.
The historical rank and industry rank for Gujarat Themis Biosyn's Days Inventory or its related term are showing as below:
NSE:GUJTHEM'
s Days Inventory Range Over the Past 10 Years
Min: 33.19 Med: 76.91 Max: 155.51
Current: 122.11
During the past 13 years, Gujarat Themis Biosyn's highest Days Inventory was 155.51. The lowest was 33.19. And the median was 76.91.
NSE:GUJTHEM's Days Inventory is ranked better than 69.06% of 921
companies
in the Drug Manufacturers industry
Industry Median: 164.48
vs NSE:GUJTHEM: 122.11
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Gujarat Themis Biosyn's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.32.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Gujarat Themis Biosyn's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.35.
Gujarat Themis Biosyn (NSE:GUJTHEM) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Gujarat Themis Biosyn's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Gujarat Themis Biosyn's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Gujarat Themis Biosyn Days Inventory Related Terms
Gujarat Themis Biosyn Days Inventory Historical Data
* Premium members only.
The historical data trend for Gujarat Themis Biosyn's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:GUJTHEM vs ZTS, UTHR: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Gujarat Themis Biosyn's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gujarat Themis Biosyn Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Gujarat Themis Biosyn's Days Inventory distribution charts can be found below:
* The bar in red indicates where Gujarat Themis Biosyn's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Gujarat Themis Biosyn (NSE:GUJTHEM) has a Days Inventory of 287.17 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Gujarat Themis Biosyn and its competitors. This is 273% above median its historical median of 76.91. Over the past decade, Gujarat Themis Biosyn's Days Inventory has ranged from 33.19 to 155.51. According to the industry distribution chart, Gujarat Themis Biosyn ranks #285 out of 921 companies in the Drug Manufacturers industry, placing it in the top 30.9%.
Is Gujarat Themis Biosyn's Days Inventory too high?
Gujarat Themis Biosyn's current Days Inventory of 287.17 is 273% above median its 10-year median of 76.91. Over the past 10 years, this metric has ranged from a low of 33.19 to a high of 155.51. The Drug Manufacturers industry median Days Inventory is 164.48. Gujarat Themis Biosyn's value of 287.17 is 74.6% above this industry median. Based on the distribution chart, Gujarat Themis Biosyn ranks #285 out of 921 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Gujarat Themis Biosyn has a GF Score™ of 64/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Gujarat Themis Biosyn's Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Gujarat Themis Biosyn ranks #285 out of 921 companies for Days Inventory. This puts Gujarat Themis Biosyn in the upper half of its industry. The industry median Days Inventory is 164.48. Gujarat Themis Biosyn's value of 287.17 is 74.6% above this benchmark. Historically, Gujarat Themis Biosyn's own Days Inventory has ranged from 33.19 to 155.51 over the past decade. While the company's 10-year median is 76.91 vs. the industry median of 164.48, Gujarat Themis Biosyn has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.48, based on 921 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Gujarat Themis Biosyn's current Days Inventory of 287.17 is 74.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Gujarat Themis Biosyn and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gujarat Themis Biosyn's current Days Inventory is 287.17, which is 273% above median its own 10-year median of 76.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gujarat Themis Biosyn stock overvalued right now?
Based on GuruFocus' analysis, Gujarat Themis Biosyn (NSE:GUJTHEM) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹312.84, compared to a current price of ₹363.95 — trading 16.3% above its estimated fair value. The current Days Inventory is 287.17, which is 273% above median its 10-year median of 76.91 and 74.6% above the Drug Manufacturers industry median of 164.48. Gujarat Themis Biosyn's overall GF Score™ is 64/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Gujarat Themis Biosyn (NSE:GUJTHEM), the current Days Inventory is 287.17 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Gujarat Themis Biosyn (NSE:GUJTHEM) Overvalued in 2026?
Based on GuruFocus' analysis, Gujarat Themis Biosyn stock appears to be overvalued.
The current stock price of ₹363.95 is trading 16.3% above its estimated GF Value™ of ₹312.84.
GuruFocus considers Gujarat Themis Biosyn to be Modestly Overvalued.
Key valuation signals for NSE:GUJTHEM:
Days Inventory: 287.17 (273% above median its 10-year median of 76.91)
GF Value™: ₹312.84 vs. price of ₹363.95 (16.3% above fair value)
Industry Position: 74.6% above the Drug Manufacturers median (#285 of 921)
No single metric tells the full story. See the NSE:GUJTHEM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Gujarat Themis Biosyn Ltd is engaged in manufacturing, exporting, and selling of bulk drugs on a job-work basis. The company operates in one segment which is pharmaceuticals. Its products include Rifamycin-S, which is an intermediate for Rifampicin for the treatment of tuberculosis (TB), and Lovastatin.
64GF Score
Get the complete analysis for NSE:GUJTHEM
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:GUJTHEM has been successfully added to your 
